IFP Advisors’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
Other funds holding TCRT
DCM
MP
LCM
BC
GCP
IFP Advisors's TCRT Position: Q2 2023 in Review
IFP Advisors sold out of Alaunos Therapeutics (TCRT) in Q2 2023, closing a stake of 52 shares — an estimated $37.8K sold.
IFP Advisors first reported a position in TCRT in Q4 2015 and held it in 20 quarters. The position peaked at $84K in Q4 2022. 100 funds tracked by Wall St. Rank hold TCRT as of Q2 2023.
- IFP Advisors reported no remaining Alaunos Therapeutics position as of Q2 2023 after selling out during the quarter.
- IFP Advisors sold 52 Alaunos Therapeutics shares in Q2 2023, an estimated $37.8K.
- IFP Advisors first reported a position in Alaunos Therapeutics in Q4 2015 and held it in 20 quarters.
- IFP Advisors's Alaunos Therapeutics position peaked at $84K in Q4 2022.
- 100 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2023.
Based on IFP Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.